Corvus Pharmaceuticals (CRVS) Short Interest Ratio & Short Volume $5.01 +0.28 (+5.92%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Corvus Pharmaceuticals Short Interest DataCorvus Pharmaceuticals (CRVS) has a short interest of 5.43 million shares. This marks a 25.99% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 1.62 million shares to cover all short positions.Current Short Interest5,430,000 sharesPrevious Short Interest4,310,000 sharesChange Vs. Previous Month+25.99%Dollar Volume Sold Short$29.05 millionShort Interest Ratio4.7 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares64,260,000 sharesPercentage of Shares Shorted8.45%Today's Trading Volume719,048 sharesAverage Trading Volume1,624,622 sharesToday's Volume Vs. Average44% Short Selling Corvus Pharmaceuticals? Sign up to receive the latest short interest report for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRVS Short Interest Over TimeCRVS Days to Cover Over TimeCRVS Percentage of Float Shorted Over Time Corvus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20245,430,000 shares $29.05 million +26.0%N/A4.7 $5.35 12/15/20244,310,000 shares $31.81 million +22.8%N/A4 $7.38 11/30/20243,510,000 shares $31.91 million +6.4%N/A4.5 $9.09 11/15/20243,300,000 shares $27.03 million +12.6%N/A4.5 $8.19 10/31/20242,930,000 shares $25.90 million +20.1%N/A4.6 $8.84 10/15/20242,440,000 shares $16.40 million +13.5%N/A4.6 $6.72 9/30/20242,150,000 shares $11.35 million +31.1%N/A5.4 $5.28 9/15/20241,640,000 shares $8.36 million +14.7%N/A4.5 $5.10 8/31/20241,430,000 shares $6.41 million +4.4%N/A4.9 $4.48 8/15/20241,370,000 shares $5.21 million +19.1%N/A5.3 $3.80 Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,150,000 shares $2.96 million -8.0%N/A4.7 $2.57 7/15/20241,250,000 shares $2.50 million -12.6%N/A5.8 $2.00 6/30/20241,430,000 shares $2.60 million -4.7%N/A6.6 $1.82 6/15/20241,500,000 shares $3.06 million -1.3%N/A6.5 $2.04 5/31/20241,520,000 shares $3.28 million +17.8%N/A6.5 $2.16 5/15/20241,290,000 shares $2.86 million -5.2%N/A5.2 $2.22 4/30/20241,360,000 shares $2.11 million -0.7%3.7%5.4 $1.55 4/15/20241,370,000 shares $2.01 million -2.1%3.7%7 $1.47 3/31/20241,400,000 shares $2.49 million -6.0%3.8%6.6 $1.78 3/15/20241,490,000 shares $2.83 million +17.3%4.0%6.8 $1.90 2/29/20241,270,000 shares $2.84 million No Change3.4%5.7 $2.24 2/15/20241,270,000 shares $2.98 million -8.0%3.4%6.2 $2.35 1/31/20241,380,000 shares $2.76 million -1.4%3.7%6.3 $2.00 1/15/20241,400,000 shares $3.28 million +5.3%3.8%6 $2.34 12/31/20231,330,000 shares $2.34 million +2.3%3.6%6.1 $1.76 12/15/20231,300,000 shares $1.99 million -17.2%3.5%6.5 $1.53 11/30/20231,570,000 shares $2.40 million -12.3%4.3%7.9 $1.53 11/15/20231,790,000 shares $2.70 million +4.7%4.9%6.4 $1.51 10/31/20231,710,000 shares $1.93 million -3.4%4.6%6.4 $1.13 10/15/20231,770,000 shares $2.48 million No Change4.8%7.1 $1.40 9/30/20231,770,000 shares $2.58 million -2.8%4.8%6.1 $1.46 9/15/20231,820,000 shares $2.88 million +32.9%4.9%5 $1.58 8/31/20231,370,000 shares $2.90 million +21.2%3.8%2.3 $2.12 8/15/20231,130,000 shares $2.44 million -2.6%3.1%1.8 $2.16 7/31/20231,160,000 shares $2.61 million -17.7%3.4%1.1 $2.25 7/15/20231,410,000 shares $3.47 million +11.9%4.1%1.3 $2.46 6/30/20231,260,000 shares $2.89 million +61.4%3.7%1.1 $2.29 6/15/2023780,600 shares $1.94 million -19.8%2.3%0.7 $2.49 5/31/2023973,100 shares $2.96 million +113.6%2.8%1.1 $3.04 5/15/2023455,500 shares $1.18 million +209.2%1.3%0.6 $2.60Missed Tesla? Don’t Miss Elon's Next Big Move (Ad)I believe Elon's next venture, his "Final Move," could mint more millionaires than any project he's ever been a part of before.Click Here to see why - and get all the details on how you could join him >>> 4/30/2023147,300 shares $159,084.00 -38.3%0.4%0.6 $1.08 4/15/2023238,700 shares $248,248.00 +50.8%0.7%1.1 $1.04 3/31/2023158,300 shares $144,053.00 -20.9%0.5%0.8 $0.91 3/15/2023200,200 shares $144,144.00 +16.9%0.6%2.1 $0.72 2/28/2023171,200 shares $124,976.00 +35.9%0.5%1.4 $0.73 2/15/2023126,000 shares $97,007.40 +13.7%0.4%1 $0.77 1/31/2023110,800 shares $90,856.00 -34.9%0.3%0.8 $0.82 1/15/2023170,100 shares $154,791.00 -3.7%0.5%1.2 $0.91 12/30/2022176,700 shares $150,195.00 +17.3%0.5%1.2 $0.85 12/15/2022150,600 shares $126,353.40 -53.8%0.4%1 $0.84 11/30/2022325,900 shares $303,803.98 +58.1%0.9%2.2 $0.93 11/15/2022206,100 shares $187,963.20 -0.5%0.6%1.3 $0.91 10/31/2022207,100 shares $179,555.70 -12.4%0.6%1 $0.87 10/15/2022236,500 shares $215,215.00 +16.3%0.7%0.9 $0.91 9/30/2022203,300 shares $166,401.05 +1.6%0.6%0.7 $0.82 9/15/2022200,200 shares $191,191.00 +70.8%0.6%0.6 $0.96 8/31/2022117,200 shares $112,336.20 -64.5%0.3%0.4 $0.96 8/15/2022330,500 shares $371,812.50 -75.2%1.0%1.1 $1.13 7/31/20221,330,000 shares $1.17 million +70.1%3.9%4.7 $0.88 7/15/2022782,000 shares $774,962.00 -15.2%2.3%3.2 $0.99 6/30/2022922,500 shares $913,367.25 +306.2%2.7%3.6 $0.99 6/15/2022227,100 shares $224,806.29 +18.5%0.7%0.9 $0.99 5/31/2022191,600 shares $197,348.00 -22.9%0.6%0.8 $1.03 5/15/2022248,600 shares $258,544.00 +28.6%0.7%1 $1.04 4/30/2022193,300 shares $253,223.00 +5.2%0.6%0.8 $1.31 4/15/2022183,800 shares $266,510.00 -14.9%0.5%0.7 $1.45 3/31/2022215,900 shares $354,076.00 +5.2%0.6%0.7 $1.64 3/15/2022205,200 shares $299,592.00 +3.0%0.6%0.6 $1.46 2/28/2022199,200 shares $352,584.00 -41.3%0.6%0.5 $1.77 2/15/2022339,300 shares $692,172.00 +101.5%1.0%0.7 $2.04 1/31/2022168,400 shares $303,120.00 -43.8%0.5%0.3 $1.80 1/15/2022299,500 shares $673,875.00 +34.0%N/A0 $2.25 12/31/2021223,500 shares $538,635.00 -31.2%0.7%0.3 $2.41 12/15/2021324,700 shares $892,925.00 -43.0%1.0%0.2 $2.75 11/30/2021569,200 shares $1.94 million -45.8%1.9%0.1 $3.41 11/15/20211,050,000 shares $3.89 million -42.9%3.5%0.1 $3.70 10/29/20211,840,000 shares $8.34 million +3.4%6.2%0.2 $4.53 10/15/20211,780,000 shares $8.81 million -42.2%6.3%0.2 $4.95 9/30/20213,080,000 shares $14.91 million +318.7%10.9%0.4 $4.84 9/15/2021735,600 shares $1.68 million +45.0%2.5%0.1 $2.29 8/31/2021507,200 shares $1.15 million -48.0%1.8%2.1 $2.26 8/13/2021975,800 shares $1.93 million -22.6%3.5%4.4 $1.98 7/30/20211,260,000 shares $2.63 million +3.3%4.5%5.3 $2.09 7/15/20211,220,000 shares $2.84 million +0.8%3.7%4.1 $2.33 6/30/20211,210,000 shares $3.23 million +7.1%3.7%4.2 $2.67 6/15/20211,130,000 shares $3.10 million -8.9%3.4%3.5 $2.74 5/28/20211,240,000 shares $3.40 million +3.3%3.8%3.4 $2.74 5/14/20211,200,000 shares $2.95 million -9.1%N/A2.1 $2.46 4/30/20211,320,000 shares $3.72 million -1.5%N/A1.4 $2.82 4/15/20211,340,000 shares $3.79 million -7.6%N/A1.5 $2.83Missed Tesla? Don’t Miss Elon's Next Big Move (Ad)I believe Elon's next venture, his "Final Move," could mint more millionaires than any project he's ever been a part of before.Click Here to see why - and get all the details on how you could join him >>> 3/31/20211,450,000 shares $4.26 million -8.2%N/A1.6 $2.94 3/15/20211,580,000 shares $5.10 million +24.4%N/A1.8 $3.23 2/26/20211,270,000 shares $4.55 million +2.4%N/A1.5 $3.58 2/12/20211,240,000 shares $4.89 million +0.8%N/A1.8 $3.94 1/29/20211,230,000 shares $4.54 million No Change5.7%5 $3.69 1/15/20211,230,000 shares $5.08 million +2.5%5.7%6.6 $4.13 12/31/20201,200,000 shares $4.52 million -3.2%5.6%6.8 $3.77 12/15/20201,240,000 shares $4.90 million -10.1%5.8%1.5 $3.95 11/30/20201,380,000 shares $5.56 million -0.7%6.4%1.6 $4.03 11/15/20201,390,000 shares $5.74 million -9.2%6.5%1.6 $4.13 10/30/20201,530,000 shares $6.10 million +2.7%7.1%1.7 $3.99 10/15/20201,490,000 shares $5.96 million +8.8%6.9%1.6 $4.00 9/30/20201,370,000 shares $5.49 million -14.4%6.4%1.3 $4.01 9/15/20201,600,000 shares $6.75 million -1.2%7.5%0.8 $4.22 8/31/20201,620,000 shares $6.14 million +2.5%7.6%0.8 $3.79 8/14/20201,580,000 shares $6.35 million -2.5%7.4%0.8 $4.02 7/31/20201,620,000 shares $6.87 million +25.6%7.6%0.8 $4.24 7/15/20201,290,000 shares $4.91 million +204.1%6.0%0.6 $3.81 6/30/2020424,200 shares $1.15 million +0.3%2.1%0.2 $2.72 6/15/2020422,900 shares $1.31 million +29.0%2.1%3.2 $3.10 5/29/2020327,800 shares $1.20 million -72.5%1.7%2.2 $3.66 5/15/20201,190,000 shares $4.18 million -4.0%6.0%7.9 $3.51 4/30/20201,240,000 shares $3.14 million -1.6%5.4%8 $2.53 4/15/20201,260,000 shares $2.94 million No Change4.8%8.3 $2.33 3/31/20201,260,000 shares $3.38 million +1.0%5.9%7.4 $2.68 3/13/20201,248,100 shares $2.78 million -2.5%5.9%5.9 $2.23 2/28/20201,280,000 shares $2.60 million -3.8%6.0%6.1 $2.03 2/14/20201,330,000 shares $3.72 million +4.7%6.2%6.4 $2.80 1/31/20201,270,000 shares $4.71 million -5.9%6.0%6.3 $3.71 CRVS Short Interest - Frequently Asked Questions What is Corvus Pharmaceuticals' current short interest? Short interest is the volume of Corvus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 5,430,000 shares of CRVS short. Learn More on Corvus Pharmaceuticals' current short interest. What is a good short interest ratio for Corvus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRVS shares currently have a short interest ratio of 5.0. Learn More on Corvus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Corvus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corvus Pharmaceuticals: Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Corvus Pharmaceuticals' short interest increasing or decreasing? Corvus Pharmaceuticals saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 5,430,000 shares, an increase of 26.0% from the previous total of 4,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Corvus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Corvus Pharmaceuticals: Kiniksa Pharmaceuticals, Ltd. (4.70%), Maravai LifeSciences Holdings, Inc. (3.37%), Arcus Biosciences, Inc. (15.73%), Ocular Therapeutix, Inc. (6.83%), Arvinas, Inc. (13.80%), Calliditas Therapeutics AB (publ) (0.01%), Praxis Precision Medicines, Inc. (10.98%), Day One Biopharmaceuticals, Inc. (25.54%), ANI Pharmaceuticals, Inc. (10.22%), Aurinia Pharmaceuticals Inc. (4.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Corvus Pharmaceuticals stock? Short selling CRVS is an investing strategy that aims to generate trading profit from Corvus Pharmaceuticals as its price is falling. CRVS shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corvus Pharmaceuticals? A short squeeze for Corvus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRVS, which in turn drives the price of the stock up even further. How often is Corvus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRVS, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies KNSA Short Interest Data MRVI Short Interest Data RCUS Short Interest Data OCUL Short Interest Data ARVN Short Interest Data CALT Short Interest Data PRAX Short Interest Data DAWN Short Interest Data ANIP Short Interest Data AUPH Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRVS) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRVS Stock Alerts